Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
40,550.00
+1,600.00
+(4.11%)
At close: 3:30:18 PM GMT+9
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
5,066,620
3,706,059
9,456,043
4,003,150
3,555,842
Cost of Revenue
4,525,204
3,292,852
1,765,018
3,564,867
3,178,919
Gross Profit
541,416
413,207
7,691,025
438,283
376,923
Operating Expense
21,595,319
20,917,472
23,994,127
47,341,232
41,933,231
Operating Income
-21,053,903
-20,504,265
-16,303,102
-46,902,949
-41,556,308
Net Non Operating Interest Income Expense
876,551
1,935,046
299,308
-336,766
41,319
Pretax Income
-18,988,938
-16,971,215
-9,820,631
-47,151,335
-41,664,755
Tax Provision
-91,211
253,149
1,315,581
218,271
123,682
Net Income Common Stockholders
-18,897,727
-17,224,364
-11,136,212
-47,369,606
-41,788,437
Basic EPS
-250.60
-240.20
-168.00
-773.60
-684.40
Diluted EPS
-250.60
-240.20
-168.00
-773.60
-684.40
Basic Average Shares
75,248.93
71,708.43
66,286.98
61,232.69
61,058.50
Diluted Average Shares
75,248.93
71,708.43
66,286.98
61,232.69
61,058.50
Total Operating Income as Reported
-21,053,902
-20,504,264
-16,303,104
-46,902,949
-41,556,307
Rent Expense Supplemental
329,436
673,089
627,322
533,693
588,620
Total Expenses
26,120,523
24,210,324
25,759,145
50,906,099
45,112,150
Net Income from Continuing & Discontinued Operation
-18,897,727
-17,224,364
-11,136,212
-47,369,606
-41,788,437
Normalized Income
-18,893,875.59
-17,216,217.52
-11,132,554.30
-47,214,477.35
-41,788,399.04
Interest Income
1,395,129
2,220,869
670,490
129,690
876,574
Interest Expense
518,578
285,823
371,182
466,456
835,255
Net Interest Income
876,551
1,935,046
299,308
-336,766
41,319
EBIT
-18,470,360
-16,685,392
-9,449,449
-46,684,879
-40,829,500
EBITDA
-17,700,382
-15,273,676
-7,784,463
-45,134,020
-39,187,046
Reconciled Cost of Revenue
4,525,204
3,292,852
1,765,018
3,564,867
3,178,919
Reconciled Depreciation
769,978
1,411,716
1,664,986
1,550,859
1,642,454
Net Income from Continuing Operation Net Minority Interest
-18,897,727
-17,224,364
-11,136,212
-47,369,606
-41,788,437
Total Unusual Items Excluding Goodwill
-3,870
-10,312
-4,630
-212,505
-52
Total Unusual Items
-3,870
-10,312
-4,630
-212,505
-52
Normalized EBITDA
-17,696,512
-15,263,364
-7,779,833
-44,921,515
-39,186,994
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-18.59
-2,165.52
-972.30
-57,376.35
-14.04
12/31/2020 - 11/6/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
365270.KQ curacle co.,ltd.
7,270.00
-8.55%
228760.KQ Genomictree Inc.
20,150.00
-0.25%
298380.KQ ABL Bio Inc.
42,000.00
-0.83%
196170.KQ ALTEOGEN Inc.
414,000.00
+3.50%
REGN Regeneron Pharmaceuticals, Inc.
675.49
-1.37%
ENVB Enveric Biosciences, Inc.
2.1200
-18.46%
RXRX Recursion Pharmaceuticals, Inc.
6.47
-1.82%
MRNA Moderna, Inc.
30.37
+0.33%